Tag Archives: TAU

Tel Aviv University and the quest for super-slim, bendable displays

Leave a reply

It’s beginning to seem like the quest for the Holy Grail. That is, the search for an object more myth than fact, but researchers at Tel Aviv University (TAU) believe they are on the right track to develop a slim, flexible screen according to a March 30, 2015 news item on Nanowerk (Note: A link has been removed),

From smartphones and tablets to computer monitors and interactive TV screens, electronic displays are everywhere. As the demand for instant, constant communication grows, so too does the urgency for more convenient portable devices — especially devices, like computer displays, that can be easily rolled up and put away, rather than requiring a flat surface for storage and transportation.

A new Tel Aviv University study, published recently in Nature Nanotechnology (“Light-emitting self-assembled peptide nucleic acids exhibit both stacking interactions and Watson–Crick base pairing”), suggests that a novel DNA-peptide structure can be used to produce thin, transparent, and flexible screens. The research, conducted by Prof. Ehud Gazit and doctoral student Or Berger of the Department of Molecular Microbiology and Biotechnology at TAU’s Faculty of Life Sciences, in collaboration with Dr. Yuval Ebenstein and Prof. Fernando Patolsky of the School of Chemistry at TAU’s Faculty of Exact Sciences, harnesses bionanotechnology to emit a full range of colors in one pliable pixel layer — as opposed to the several rigid layers that constitute today’s screens.

A March 30, 2015 American Friends of Tel Aviv University news release, which originated the news item, describes the material’s advantages and how the researchers developed it,

“Our material is light, organic, and environmentally friendly,” said Prof. Gazit. “It is flexible, and a single layer emits the same range of light that requires several layers today. By using only one layer, you can minimize production costs dramatically, which will lead to lower prices for consumers as well.”

…

For the purpose of the study, a part of Berger’s Ph.D. thesis, the researchers tested different combinations of peptides: short protein fragments, embedded with DNA elements which facilitate the self-assembly of a unique molecular architecture.

Peptides and DNA are two of the most basic building blocks of life. Each cell of every life form is composed of such building blocks. In the field of bionanotechnology, scientists utilize these building blocks to develop novel technologies with properties not available for inorganic materials such as plastic and metal.

“Our lab has been working on peptide nanotechnology for over a decade, but DNA nanotechnology is a distinct and fascinating field as well. When I started my doctoral studies, I wanted to try and converge the two approaches,” said Berger. “In this study, we focused on PNA — peptide nucleic acid, a synthetic hybrid molecule of peptides and DNA. We designed and synthesized different PNA sequences, and tried to build nano-metric architectures with them.”

Using methods such as electron microscopy and X-ray crystallography, the researchers discovered that three of the molecules they synthesized could self-assemble, in a few minutes, into ordered structures. The structures resembled the natural double-helix form of DNA, but also exhibited peptide characteristics. This resulted in a very unique molecular arrangement that reflects the duality of the new material.

“Once we discovered the DNA-like organization, we tested the ability of the structures to bind to DNA-specific fluorescent dyes,” said Berger. “To our surprise, the control sample, with no added dye, emitted the same fluorescence as the variable. This proved that the organic structure is itself naturally fluorescent.”

…

The structures were found to emit light in every color, as opposed to other fluorescent materials that shine only in one specific color. Moreover, light emission was observed also in response to electric voltage — which make it a perfect candidate for opto-electronic devices like display screens.

Here’s a link to and a citation for the paper,

Light-emitting self-assembled peptide nucleic acids exhibit both stacking interactions and Watson–Crick base pairing by Or Berger, Lihi Adler-Abramovich, Michal Levy-Sakin, Assaf Grunwald, Yael Liebes-Peer, Mor Bachar, Ludmila Buzhansky, Estelle Mossou, V. Trevor Forsyth, Tal Schwartz, Yuval Ebenstein, Felix Frolow, Linda J. W. Shimon, Fernando Patolsky, & Ehud Gazit. Nature Nanotechnology (2015) doi:10.1038/nnano.2015.27 Published online 16 March 2015

This paper is behind a paywall but a free preview is available via ReadCube Access.

Tackling ‘untreatable’ brain tumours

Leave a reply

Isreal’s Tel Aviv University (TAU) has announced research that combines a nanoparticle-platform with RNA (ribonucleic acid) interference (RNAi) therapy for a difficult to treat brain cancer. From a Feb. 24, 2015 news item on Nanowerk,

There are no effective available treatments for sufferers of Glioblastoma multiforme (GBM), the most aggressive and devastating form of brain tumor. The disease, always fatal, has a survival rate of only 6-18 months.

Now a new Tel Aviv University study may offer hope to the tens of thousands diagnosed with gliomas every year. A pioneer of cancer-busting nanoscale therapeutics, Prof. Dan Peer of TAU’s Department of Department of Cell Research and Immunology and Scientific Director of TAU’s Center for NanoMedicine has adapted an earlier treatment modality — one engineered to tackle ovarian cancer tumors — to target gliomas, with promising results.

A Feb. 24, 2015 American Friends of Tel Aviv University news release (also on EurekAlert), which originated the news item, describes how the two lead researchers came to collaborate on this project,

“I was approached by a neurosurgeon insistent on finding a solution, any solution, to a desperate situation,” said Prof. Peer. “Their patients were dying on them, fast, and they had virtually no weapons in their arsenal. Prof. Zvi Cohen heard about my earlier nanoscale research and suggested using it as a basis for a novel mechanism with which to treat gliomas.”

Dr. Cohen had acted as the primary investigator in several glioma clinical trials over the last decade, in which new treatments were delivered surgically into gliomas or into the surrounding tissues following tumor removal. “Unfortunately, gene therapy, bacterial toxin therapy, and high-intensity focused ultrasound therapy had all failed as approaches to treat malignant brain tumors,” said Dr. Cohen. “I realized that we must think differently. When I heard about Dan’s work in the field of nanomedicine and cancer, I knew I found an innovative approach combining nanotechnology and molecular biology to tackle brain cancer.”

The news release then describes the research in more detail,

Dr. Peer’s new research is based on a nanoparticle platform, which transports drugs to target sites while minimizing adverse effects on the rest of the body. Prof. Peer devised a localized strategy to deliver RNA genetic interference (RNAi) directly to the tumor site using lipid-based nanoparticles coated with the polysugar hyaluronan (HA) that binds to a receptor expressed specifically on glioma cells. Prof. Peer and his team of researchers tested the therapy in mouse models affected with gliomas and control groups treated with standard forms of chemotherapy. The results were, according to the researchers, astonishing.

“We used a human glioma implanted in mice as our preclinical model,” said Prof. Peer. “Then we injected our designed particle with fluorescent dye to monitor its success entering the tumor cells. We were pleased and astonished to find that, a mere three hours later, the particles were situated within the tumor cells.”

…

Rather than chemotherapy, Prof. Peer’s nanoparticles contain nucleic acid with small interference RNAs, which silence the functioning of a key protein involved in cell proliferation. “Cancer cells, always dividing, are regulated by a specific protein,” said Prof. Peer. “We thought if we could silence this gene, they would die off. It is a basic, elegant mechanism and much less toxic than chemotherapy. This protein is not expressed in normal cells, so it only works where cells are highly proliferated.”

100 days following the treatment of four injections over 30 days, 60 percent of the afflicted mice were still alive. This represents a robust survival rate for mice, whose average life expectancy is only two years. The control mice died 30-34.5 days into treatment.

“This is a proof of concept study which can be translated into a novel clinical modality,” said Prof. Peer. “While it is in early stages, the data is so promising — it would be a crime not to pursue it.”

Here’s a link to and a citation for the paper,

Localized RNAi Therapeutics of Chemoresistant Grade IV Glioma Using Hyaluronan-Grafted Lipid-Based Nanoparticles by Zvi R. Cohen, Srinivas Ramishetti, Naama Peshes-Yaloz, Meir Goldsmith, Anton Wohl, Zion Zibly, and Dan Peer. ACS Nano, 2015, 9 (2), pp 1581–1591 DOI: 10.1021/nn506248s Publication Date (Web): January 5, 2015
Copyright © 2015 American Chemical Society

This study is behind a paywall.

Theranostics (nanomedicine) in Israel

Leave a reply

There’s a very intriguing nanomedicine project in Tel Aviv, Israel. Called Nanomedicines for Personalized Theranostics, the project combines diagnostics and therapeutics for a personalized medical experience. From the Oct. 19, 2012 news item on Nanowerk (Note: I have removed a link),

Tel Aviv University [TAU] has been appointed by the Israel National Nanotechnology Initiative (INNI) to lead a consortium on “Nanomedicines for Personalized Theranostics”, a combined system of diagnostics and therapeutic treatments. This consortium of 11 laboratories will be dedicated to developing nano-sized drug delivery systems for the detection and treatment of various diseases. Eight of the labs are TAU-led, with additional participation from Hebrew University Jerusalem, Bar-Ilan University and Ben Gurion University of the Negev.

The ultimate goal is to design a new class of drugs that can destroy faulty proteins in angiogenesis-dependent diseases that involve the growth of new blood vessels from existing vessels — including cancer, infectious diseases and heart diseases — and deliver these drugs safely into the body. Beyond the academic realm, the group aims to create spin-off companies based on licensed technologies they develop, creating the basis for a thriving biotechnology industry within Israel.

The news item provides some insight into the situation in Israel,

Although considered a beacon of research and development, the field of biotechnology in Israel has suffered drawbacks, both in academia and industry. Higher salaries lure the best minds abroad, and international companies have more private capital with which to sustain businesses.

“Israel has amazing intellectual resources, but we are constantly combating budget constraints. With this project, the idea is to create future technologies built on Israeli creativity that also allow us to bring in the brightest people and better funding,” says Prof. Peer [Scientific Director Prof. Dan Peer]. While many great biotechnology ideas were born in Israel, the economic situation stymied the establishment of many more successful companies within the country, he observes. “We want to maintain the advantages that we have in the life sciences while boosting this lagging industry. Our research as part of the FTA [the Focal Technology Area within the INNI] will be a starting engine.”

Prof. Peer hopes that in two years, researchers will be able to start translating their research into practical applications.

The INNI is also working to combat “brain drain” in the academic world by giving TAU and other institutions the means to attract outstanding young researchers back home to Israel, both with funding and with the prestige of the project.

Is there a country in the world that isn’t concerned about ‘brain drain’?

Blood-, milk-, and mucus-powered electronics

Leave a reply

Researchers at Tel Aviv University ([TAU] Israel) have already begun to develop biodegradable display screens in their quest to create electronic devices powered by blood, milk, and mucus proteins found in our bodies. From the March 7, 2012 news item on Nanowerk,

… a team including Ph.D. students Elad Mentovich and Netta Hendler of TAU’s Department of Chemistry and The Center for Nanoscience and Nanotechnology, with supervisor Dr. Shachar Richter and in collaboration with Prof. Michael Gozin and his Ph.D. student Bogdan Belgorodsky, has brought together cutting-edge techniques from multiple fields of science to create protein-based transistors — semi-conductors used to power electronic devices — from organic materials found in the human body. They could become the basis of a new generation of nano-sized technologies that are both flexible and biodegradable.

The March 7, 2012 news release on the American Friend of TAU website notes some of the issues with silicon-based electronics,

One of the challenges of using silicon as a semi-conductor is that a transistor must be created with a “top down” approach. Manufacturers start with a sheet of silicon and carve it into the shape that is needed, like carving a sculpture out of a rock. This method limits the capabilities of transistors when it comes to factors such as size and flexibility.

The TAU researchers turned to biology and chemistry for a different approach to building the ideal transistor. When they applied various combinations of blood, milk, and mucus proteins to any base material, the molecules self-assembled to create a semi-conducting film on a nano-scale. In the case of blood protein, for example, the film is approximately four nanometers high. The current technology in use now is 18 nanometers, says Mentovich.

Together, the three different kinds of proteins create a complete circuit with electronic and optical capabilities, each bringing something unique to the table. Blood protein has the ability to absorb oxygen, Mentovich says, which permits the “doping” of semi-conductors with specific chemicals in order to create specific technological properties. Milk proteins, known for their strength in difficult environments, form the fibers which are the building blocks of the transistors, while the mucosal proteins have the ability to keep red, green and, blue fluorescent dyes separate, together creating the white light emission that is necessary for advanced optics.

Overall, the natural abilities of each protein give the researchers “unique control” over the resulting organic transistor, allowing adjustments for conductivity, memory storage, and fluorescence among other characteristics.

I have previously featured work on vampire (blood-powered) fuel cells and batteries  in my July 18, 2012 posting and my April 3, 2009 posting so the notion of using blood (and presumably other bodily fluids) as a source for electrical power is generating (pun intended, weak though it is) interest in many research labs.

While the researchers don’t speculate about integrating these new carbon-based devices, which are smaller and more flexible than current devices, in bodies (from the American Friends of TAU news release),

Technology is now shifting from a silicon era to a carbon era, notes Mentovich, and this new type of transistor could play a big role. Transistors built from these proteins will be ideal for smaller, flexible devices that are made out of plastic rather than silicon, which exists in wafer form that would shatter like glass if bent. The breakthrough could lead to a new range of flexible technologies, such as screens, cell phones and tablets, biosensors, and microprocessor chips.

Just as significant, because the researchers are using natural proteins to build their transistor, the products they create will be biodegradable. It’s a far more environmentally friendly technology that addresses the growing problem of electronic waste, which is overflowing landfills worldwide.

The biodegradability of these proposed devices may be a problem if they are integrated into our bodies but it is certain that this will be attempted as we continue to explore machine/flesh possibilities.

Rats with robot brains

1 Reply

A robotic cerebellum has been implanted into a rat’s skull. From the Oct. 4, 2011 news item on Science Daily,

With new cutting-edge technology aimed at providing amputees with robotic limbs, a Tel Aviv University researcher has successfully implanted a robotic cerebellum into the skull of a rodent with brain damage, restoring its capacity for movement.

The cerebellum is responsible for co-ordinating movement, explains Prof. Matti Mintz of TAU’s [Tel Aviv University] Department of Psychology. When wired to the brain, his “robo-cerebellum” receives, interprets, and transmits sensory information from the brain stem, facilitating communication between the brain and the body. To test this robotic interface between body and brain, the researchers taught a brain-damaged rat to blink whenever they sounded a particular tone. The rat could only perform the behavior when its robotic cerebellum was functional.

This is the third item I’ve found in the last few weeks about computer chips being implanted in brains. I found the other two items in a discussion about extreme human enhancement on Slate.com (first mentioned in my Sept. 15, 2011 posting). One of the Brad Allenby [the other two discussants are Nicholas Agar and Kyle Munkittrick] entries (posted Sept. 16, 2011) featured these two references,

Experiments that began here at Arizona State University and have been continued at Duke and elsewhere have involved monkeys learning to move mechanical arms to which they are wirelessly connected as if they were part of themselves, using them effectively even when the arms (but not the monkey) are shifted up to MIT and elsewhere. More recently, monkeys with chips implanted in their brains [2008 according to the video on the website] at Duke University have kept a robot wirelessly connected to their chip running in Japan. Similar technologies are being explored to enable paraplegics and other injured people to interact with their environments and to communicate effectively, as well. The upshot is that “the body” is becoming more than just a spatial presence; rather, it becomes a designed extended cognitive network.

The projects are almost mirror images of each other. The rat can’t move without input from its robotic cerebellum while the monkeys control the robots’ movement with their thoughts. From the Oct. 3, 2011 news release on Eureka Alert,

According to the researcher, the chip is designed to mimic natural neuronal activity. “It’s a proof of the concept that we can record information from the brain, analyze it in a way similar to the biological network, and then return it to the brain,” says Prof. Mintz, who recently presented his research at the Strategies for Engineered Negligible Senescence meeting in Cambridge, UK.

In reading these items, I can’t help but remember that plastic surgery was a means of helping soldiers with horrendous wounds and it has now become part of the cosmetics industry. Given that history, it is possible to imagine (or to assume) that these brain ‘repairs’ could be used to augment or reshape our brains to increase intelligence, heighten senses, improve motor coordination, etc. In short. to accomplish very different goals than those originally set out.